Baseline clinical characteristics did not differ between atorvastatin and placebo groups ( mean age 59.3 + / - 13.4 vs 61.1 + / - 11.5 , P = ns ) ; myocardial infarction 52.3 % versus 67.4 % ( P = ns ) .
